CONSTELLIUM SE (CSTM) Fundamental Analysis & Valuation

NYSE:CSTM • FR0013467479

25.33 USD
-0.16 (-0.63%)
At close: Mar 11, 2026
24.6385 USD
-0.69 (-2.73%)
After Hours: 3/11/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CSTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CSTM. CSTM was compared to 157 industry peers in the Metals & Mining industry. While CSTM belongs to the best of the industry regarding profitability, there are concerns on its financial health. CSTM scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

7

1. CSTM Profitability Analysis

1.1 Basic Checks

  • CSTM had positive earnings in the past year.
  • In the past year CSTM had a positive cash flow from operations.
  • Each year in the past 5 years CSTM has been profitable.
  • In the past 5 years CSTM always reported a positive cash flow from operatings.
CSTM Yearly Net Income VS EBIT VS OCF VS FCFCSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.10%, CSTM is in the better half of the industry, outperforming 73.89% of the companies in the same industry.
  • CSTM's Return On Equity of 28.68% is amongst the best of the industry. CSTM outperforms 93.63% of its industry peers.
  • CSTM has a better Return On Invested Capital (10.44%) than 79.62% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CSTM is below the industry average of 11.53%.
  • The last Return On Invested Capital (10.44%) for CSTM is above the 3 year average (9.00%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.1%
ROE 28.68%
ROIC 10.44%
ROA(3y)3.12%
ROA(5y)4.2%
ROE(3y)19.26%
ROE(5y)38.55%
ROIC(3y)9%
ROIC(5y)9.09%
CSTM Yearly ROA, ROE, ROICCSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

1.3 Margins

  • CSTM's Profit Margin of 3.23% is fine compared to the rest of the industry. CSTM outperforms 63.06% of its industry peers.
  • CSTM's Profit Margin has declined in the last couple of years.
  • CSTM has a Operating Margin of 5.56%. This is comparable to the rest of the industry: CSTM outperforms 57.96% of its industry peers.
  • CSTM's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CSTM (14.05%) is comparable to the rest of the industry.
  • CSTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.56%
PM (TTM) 3.23%
GM 14.05%
OM growth 3Y9.29%
OM growth 5Y4.98%
PM growth 3Y-4.48%
PM growth 5YN/A
GM growth 3Y20.09%
GM growth 5Y7.39%
CSTM Yearly Profit, Operating, Gross MarginsCSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CSTM Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CSTM is creating some value.
  • CSTM has less shares outstanding than it did 1 year ago.
  • CSTM has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CSTM has been reduced compared to a year ago.
CSTM Yearly Shares OutstandingCSTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
CSTM Yearly Total Debt VS Total AssetsCSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • CSTM has an Altman-Z score of 2.55. This is not the best score and indicates that CSTM is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of CSTM (2.55) is worse than 61.15% of its industry peers.
  • CSTM has a debt to FCF ratio of 12.23. This is a negative value and a sign of low solvency as CSTM would need 12.23 years to pay back of all of its debts.
  • CSTM has a better Debt to FCF ratio (12.23) than 61.78% of its industry peers.
  • A Debt/Equity ratio of 2.00 is on the high side and indicates that CSTM has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.00, CSTM is not doing good in the industry: 89.81% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 12.23
Altman-Z 2.55
ROIC/WACC1.09
WACC9.61%
CSTM Yearly LT Debt VS Equity VS FCFCSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.29 indicates that CSTM should not have too much problems paying its short term obligations.
  • CSTM has a worse Current ratio (1.29) than 77.07% of its industry peers.
  • A Quick Ratio of 0.51 indicates that CSTM may have some problems paying its short term obligations.
  • CSTM's Quick ratio of 0.51 is on the low side compared to the rest of the industry. CSTM is outperformed by 88.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.51
CSTM Yearly Current Assets VS Current LiabilitesCSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CSTM Growth Analysis

3.1 Past

  • CSTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 293.74%, which is quite impressive.
  • CSTM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.43% yearly.
  • CSTM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.94%.
  • CSTM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.59% yearly.
EPS 1Y (TTM)293.74%
EPS 3Y-7.43%
EPS 5YN/A
EPS Q2Q%350.71%
Revenue 1Y (TTM)-35.94%
Revenue growth 3Y1.33%
Revenue growth 5Y11.59%
Sales Q2Q%36.37%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.68% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 7.09% on average over the next years.
EPS Next Y26.85%
EPS Next 2Y21.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.97%
Revenue Next 2Y7.09%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CSTM Yearly Revenue VS EstimatesCSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
CSTM Yearly EPS VS EstimatesCSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

8

4. CSTM Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 15.64, the valuation of CSTM can be described as correct.
  • Based on the Price/Earnings ratio, CSTM is valued cheaper than 90.45% of the companies in the same industry.
  • CSTM is valuated rather cheaply when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
  • CSTM is valuated correctly with a Price/Forward Earnings ratio of 12.34.
  • Based on the Price/Forward Earnings ratio, CSTM is valued a bit cheaper than 75.16% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CSTM to the average of the S&P500 Index (24.27), we can say CSTM is valued slightly cheaper.
Industry RankSector Rank
PE 15.64
Fwd PE 12.34
CSTM Price Earnings VS Forward Price EarningsCSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CSTM is valued cheaply inside the industry as 92.36% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CSTM is valued cheaper than 87.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.52
EV/EBITDA 6.58
CSTM Per share dataCSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CSTM has a very decent profitability rating, which may justify a higher PE ratio.
  • CSTM's earnings are expected to grow with 21.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y21.68%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CSTM Dividend Analysis

5.1 Amount

  • No dividends for CSTM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CSTM Fundamentals: All Metrics, Ratios and Statistics

CONSTELLIUM SE

NYSE:CSTM (3/11/2026, 8:04:00 PM)

After market: 24.6385 -0.69 (-2.73%)

25.33

-0.16 (-0.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-18
Earnings (Next)04-28
Inst Owners93.92%
Inst Owner Change-5.36%
Ins Owners2.19%
Ins Owner Change-8.99%
Market Cap3.42B
Revenue(TTM)8.45B
Net Income(TTM)273.00M
Analysts82
Price Target29.58 (16.78%)
Short Float %3.55%
Short Ratio2.64
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)49.71%
Min EPS beat(2)-11.76%
Max EPS beat(2)111.17%
EPS beat(4)2
Avg EPS beat(4)89.77%
Min EPS beat(4)-17.42%
Max EPS beat(4)277.07%
EPS beat(8)3
Avg EPS beat(8)-87.8%
EPS beat(12)3
Avg EPS beat(12)-74.4%
EPS beat(16)5
Avg EPS beat(16)-30.87%
Revenue beat(2)1
Avg Revenue beat(2)-3.89%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)2.04%
Revenue beat(4)2
Avg Revenue beat(4)-2.65%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)3.03%
Revenue beat(8)3
Avg Revenue beat(8)-2.87%
Revenue beat(12)4
Avg Revenue beat(12)-2.4%
Revenue beat(16)7
Avg Revenue beat(16)-1.05%
PT rev (1m)26.09%
PT rev (3m)43.21%
EPS NQ rev (1m)74.41%
EPS NQ rev (3m)60.69%
EPS NY rev (1m)21.01%
EPS NY rev (3m)40.76%
Revenue NQ rev (1m)13.95%
Revenue NQ rev (3m)13.4%
Revenue NY rev (1m)17.9%
Revenue NY rev (3m)19.01%
Valuation
Industry RankSector Rank
PE 15.64
Fwd PE 12.34
P/S 0.4
P/FCF 21.52
P/OCF 7
P/B 3.59
P/tB 4.19
EV/EBITDA 6.58
EPS(TTM)1.62
EY6.4%
EPS(NY)2.05
Fwd EY8.1%
FCF(TTM)1.18
FCFY4.65%
OCF(TTM)3.62
OCFY14.29%
SpS62.55
BVpS7.05
TBVpS6.05
PEG (NY)0.58
PEG (5Y)N/A
Graham Number16.03
Profitability
Industry RankSector Rank
ROA 5.1%
ROE 28.68%
ROCE 13.22%
ROIC 10.44%
ROICexc 10.81%
ROICexgc 11.25%
OM 5.56%
PM (TTM) 3.23%
GM 14.05%
FCFM 1.88%
ROA(3y)3.12%
ROA(5y)4.2%
ROE(3y)19.26%
ROE(5y)38.55%
ROIC(3y)9%
ROIC(5y)9.09%
ROICexc(3y)9.44%
ROICexc(5y)9.55%
ROICexgc(3y)9.86%
ROICexgc(5y)10.65%
ROCE(3y)11.4%
ROCE(5y)11.51%
ROICexgc growth 3Y1.62%
ROICexgc growth 5Y7.28%
ROICexc growth 3Y6.81%
ROICexc growth 5Y10.83%
OM growth 3Y9.29%
OM growth 5Y4.98%
PM growth 3Y-4.48%
PM growth 5YN/A
GM growth 3Y20.09%
GM growth 5Y7.39%
F-Score8
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 12.23
Debt/EBITDA 2.38
Cap/Depr 100%
Cap/Sales 3.91%
Interest Coverage 4.52
Cash Conversion 61.13%
Profit Quality 58.24%
Current Ratio 1.29
Quick Ratio 0.51
Altman-Z 2.55
F-Score8
WACC9.61%
ROIC/WACC1.09
Cap/Depr(3y)119.29%
Cap/Depr(5y)107.97%
Cap/Sales(3y)4.74%
Cap/Sales(5y)4.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)293.74%
EPS 3Y-7.43%
EPS 5YN/A
EPS Q2Q%350.71%
EPS Next Y26.85%
EPS Next 2Y21.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.94%
Revenue growth 3Y1.33%
Revenue growth 5Y11.59%
Sales Q2Q%36.37%
Revenue Next Year13.97%
Revenue Next 2Y7.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.56%
EBIT growth 3Y10.75%
EBIT growth 5Y17.15%
EBIT Next Year97.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y241.96%
FCF growth 3Y-3.51%
FCF growth 5Y0.9%
OCF growth 1Y62.46%
OCF growth 3Y2.81%
OCF growth 5Y7.92%

CONSTELLIUM SE / CSTM FAQ

What is the ChartMill fundamental rating of CONSTELLIUM SE (CSTM) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CSTM.


What is the valuation status of CONSTELLIUM SE (CSTM) stock?

ChartMill assigns a valuation rating of 8 / 10 to CONSTELLIUM SE (CSTM). This can be considered as Undervalued.


What is the profitability of CSTM stock?

CONSTELLIUM SE (CSTM) has a profitability rating of 7 / 10.


Can you provide the financial health for CSTM stock?

The financial health rating of CONSTELLIUM SE (CSTM) is 3 / 10.


How sustainable is the dividend of CONSTELLIUM SE (CSTM) stock?

The dividend rating of CONSTELLIUM SE (CSTM) is 0 / 10 and the dividend payout ratio is 0%.